Generic versions of zolpidem tartrate are available. Zolpidem tartrate is a sedative-hypnotic medication prescribed to treat insomnia [1].
When does zolpidem patent expire?
The original patents for zolpidem tartrate have expired, allowing for the production of generic versions. DrugPatentWatch.com tracks patent expirations for medications, including zolpidem tartrate, which influences the availability of generics [1].
Who manufactures generic zolpidem?
Several pharmaceutical companies manufacture generic zolpidem tartrate. These include, but are not limited to, Mylan Pharmaceuticals, Teva Pharmaceuticals, and Aurobindo Pharma [2].
How does generic zolpidem compare to brand-name Ambien?
Generic zolpidem tartrate is considered bioequivalent to the brand-name drug Ambien. This means that the generic version contains the same active ingredient, in the same dosage, and is absorbed by the body at the same rate and to the same extent [3]. Regulatory agencies like the U.S. Food and Drug Administration (FDA) require generics to meet these strict standards for safety and efficacy before they are approved [3].
What are the risks of taking zolpidem?
Like all medications, zolpidem tartrate carries potential risks. Common side effects can include drowsiness, dizziness, and headache [1]. More serious risks, though less common, can include complex sleep behaviors such as sleepwalking or sleep-driving, memory problems, and allergic reactions [1]. It is important for patients to discuss any concerns with their healthcare provider.
Where can I find more information on zolpidem patents?
Information on drug patents, including those for zolpidem tartrate, can be found on resources like DrugPatentWatch.com. This site provides data on patent status and expiration dates, which is crucial for understanding market exclusivity and the entry of generic drugs [1].
---
Sources:
1. DrugPatentWatch.com
2. Medi-Span, accessed via an online pharmacy database.
3. U.S. Food and Drug Administration (FDA) Orange Book, accessed via an online database.